Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Worldwide clinical trials for new technique for early detection of eye disease

12.10.2004


A unique new non-invasive technique for high resolution optical imaging of the eye is receiving global acclaim. The technique, pioneered by the University of Kent, is funded by the Toronto-based company, Ophthalmic Technology Inc (OTI). The University’s Applied Optics Group is currently working with university hospitals in New York (USA), Osaka (Japan), Asahikawa (Japan), Amsterdam (Netherlands) and Milan (Italy) to carry out preliminary clinical trials. By combining two high-resolution imaging technologies, the new technique provides doctors with 3-D images of the retina, macula and the optic nerve. Such high resolution images provide clinicians with capabilities for early diagnosis and treatment of common ocular diseases such as glaucoma, diabetes and age-related macula degeneration. OTI is planning in the near future to extend the clinical research to other leading university medical centres in Japan, USA and Europe.



The Kent team, based in the School of Physical Sciences, is the only research group in the world carrying out this type of work. Co-ordinated by Professor Adrian Podoleanu, it operates out of two laboratories. One is in the UK at the University’s Canterbury campus and the other is in the United States at the New York Medical College, where Adrian Podoleanu is a Visiting Professor. Other members of the team include Professor David Jackson, Dr John Rogers, a former Kent PhD student now the director of OCT Research at OTI and lecturer George Dobre.

Adrian Podoleanu explained: ‘At Kent we created a very cost effective imaging system which simultaneously produces optical coherence tomography (OCT) and scanning laser ophthalmoscope (SLO) images. Its early potential was immediately realised by OTI, who commissioned the assembly of several prototypes to be tested in different clinics worldwide before embarking on commercial exploitation of the invention’.


The first clinic to test the new instrument was at the New York Eye and Ear Infirmary. Since the first installation, OTI, The Applied Optics group in Kent and the Retina Research Lab in New York work together to further improve and enhance the performance of the technology.

Dr Richard Rosen, Director of the Retinal Imaging Laboratory, was so impressed by the results that he and his researchers have been working closely with the team ever since and are currently involved with the clinical trials.

He said: ‘The simultaneous presentation of images drawn from two technologies, developed by the Kent group has opened several exciting avenues in imaging the eye, giving us access to a world of minute details not possible to be visualised by the more conventional imaging technologies’.

The clinical investigators together with the Kent team have jointly published in international medical publications and presented at clinical and scientific conferences over 50 publications and presentations related to this research.

Posie Bogan | alfa
Further information:
http://www.kent.ac.uk

More articles from Health and Medicine:

nachricht NTU scientists build new ultrasound device using 3-D printing technology
07.12.2016 | Nanyang Technological University

nachricht How to turn white fat brown
07.12.2016 | University of Pennsylvania School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

NTU scientists build new ultrasound device using 3-D printing technology

07.12.2016 | Health and Medicine

The balancing act: An enzyme that links endocytosis to membrane recycling

07.12.2016 | Life Sciences

How to turn white fat brown

07.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>